Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00849823 · ClinicalTrials.gov registry record · NA

HIV Prevention Program for African American Teen Males

A NA study of HIV Infections and Sexually Transmitted Infections, sponsored by Richard Crosby.

Completed
Registry status
NA
Development phase
840
Enrollment target
1
Study location

NCT00849823: Completed NA study of HIV Infections and Sexually Transmitted Infections, sponsored by Richard Crosby.

NCT00849823 is a NA study of HIV Infections and Sexually Transmitted Infections that has completed, run by Richard Crosby. The registered enrollment target is 840 participants, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (89% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00849823, a NA study of HIV Infections and Sexually Transmitted Infections, has completed, sponsored by Richard Crosby.

COMPLETED
Registry status
NA
Development phase
840 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test if sexual health interventions can reduce the incidence of STIs among African American teens (15 to 21 years old). By doing this study, we hope to help African American teens improve their condom use skills and encourage them to use condoms more frequently. If the number of STIs in this population can be decreased, the health of African American teen males will greatly improve. We also believe that sexual partners (typically African American teen females) will also benefit.

Interventions

  • BEHAVIORAL Male Sexual Health Program
  • BEHAVIORAL Focus on the Future Program

Study Locations (1)

Louisiana

  • Adolescent Medicine Program, LSU School of Medicine - New Orleans

Trial Details

FieldValue
Enrollment Target 840 participants
Start Date 2009-02
Est. Completion 2013-09
Phase NA
Richard Crosby

3 total trials

What the finished NCT00849823 record still lists

NCT00849823 is an interventional study that assigns participants to a tested intervention. The registered 840 participants enrollment target is mid-sized for trials with a published cap, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (89% higher).

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Male Sexual Health Program is the first listed.

NCT00849823 reports a single indexed study location in Louisiana.

Frequently Asked Questions

What is clinical trial NCT00849823 about?

NCT00849823 is a clinical study titled "HIV Prevention Program for African American Teen Males". The purpose of this study is to test if sexual health interventions can reduce the incidence of STIs among African American teens (15 to 21 years old). By doing this study, we hope to help African American teens improve their condom use skills and encourage them to use condoms more frequently. If th...

What is the current status of trial NCT00849823?

This trial is currently completed. It is a NA study. The enrollment target is 840 participants. The study started on 2009-02. Estimated completion is 2013-09.

What conditions does trial NCT00849823 study?

This clinical trial studies the following conditions: HIV Infections, Sexually Transmitted Infections.

What interventions are being tested in trial NCT00849823?

The interventions under investigation include: Male Sexual Health Program (BEHAVIORAL), Focus on the Future Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT00849823?

This trial is sponsored by Richard Crosby, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00849823 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00849823's enrollment target sits among peer trials

840 37th of 542 higher than 506 of 542 other HIV Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04831580 · 840 participants · NA

    A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

  • NCT04976881 · 840 participants · NA

    Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes

  • NCT04985903 · 840 participants · NA

    Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women

  • NCT05384626 · 840 participants · Phase 1

    A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00849823, the US trial registry maintained by the National Library of Medicine. NCT00849823 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.